162 related articles for article (PubMed ID: 17991152)
21. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity.
Bianchi ME; Manfredi AA
Immunol Rev; 2007 Dec; 220():35-46. PubMed ID: 17979838
[TBL] [Abstract][Full Text] [Related]
22. Relationship between high-mobility group box 1 protein release and T-cell suppression in rats after thermal injury.
Zhang LT; Yao YM; Dong YQ; Dong N; Yu Y; Sheng ZY
Shock; 2008 Oct; 30(4):449-55. PubMed ID: 18277947
[TBL] [Abstract][Full Text] [Related]
23. High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy.
Dong Xda E; Ito N; Lotze MT; Demarco RA; Popovic P; Shand SH; Watkins S; Winikoff S; Brown CK; Bartlett DL; Zeh HJ
J Immunother; 2007 Sep; 30(6):596-606. PubMed ID: 17667523
[TBL] [Abstract][Full Text] [Related]
24. High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases.
Voll RE; Urbonaviciute V; Herrmann M; Kalden JR
Isr Med Assoc J; 2008 Jan; 10(1):26-8. PubMed ID: 18300566
[TBL] [Abstract][Full Text] [Related]
25. Role of cell-cell interactions in high mobility group box 1 cytokine activity in human peripheral blood mononuclear cells and mouse splenocytes.
Kohka Takahashi H; Sadamori H; Liu K; Wake H; Mori S; Yoshino T; Yamamoto Y; Yamamoto H; Nishibori M
Eur J Pharmacol; 2013 Feb; 701(1-3):194-202. PubMed ID: 23228930
[TBL] [Abstract][Full Text] [Related]
26. The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats.
Huang LF; Yao YM; Zhang LT; Dong N; Yu Y; Sheng ZY
Shock; 2009 Mar; 31(3):322-9. PubMed ID: 18665051
[TBL] [Abstract][Full Text] [Related]
27. Galectin-3-mediated xenoactivation of human monocytes.
Greenwald AG; Jin R; Waddell TK
Transplantation; 2009 Jan; 87(1):44-51. PubMed ID: 19136890
[TBL] [Abstract][Full Text] [Related]
28. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.
Hreggvidsdottir HS; Ostberg T; Wähämaa H; Schierbeck H; Aveberger AC; Klevenvall L; Palmblad K; Ottosson L; Andersson U; Harris HE
J Leukoc Biol; 2009 Sep; 86(3):655-62. PubMed ID: 19564572
[TBL] [Abstract][Full Text] [Related]
29. High Mobility Group Box 1-Protein expression in canine haematopoietic cells and influence on canine peripheral blood mononuclear cell proliferative activity.
Altmann S; Lange S; Pommerencke J; Murua Escobar H; Bullerdiek J; Nolte I; Freund M; Junghanss C
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):367-72. PubMed ID: 18762340
[TBL] [Abstract][Full Text] [Related]
30. High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo.
Faraco G; Fossati S; Bianchi ME; Patrone M; Pedrazzi M; Sparatore B; Moroni F; Chiarugi A
J Neurochem; 2007 Oct; 103(2):590-603. PubMed ID: 17666052
[TBL] [Abstract][Full Text] [Related]
31. [Influence of high mobility group box-1 protein on the correlation between regulatory T cells and CD4+ CD25- T cells of spleen in mice].
Zhang Y; Yao YM; Yu Y; Wu Y; Sheng ZY
Zhonghua Wai Ke Za Zhi; 2008 Feb; 46(3):217-20. PubMed ID: 18683721
[TBL] [Abstract][Full Text] [Related]
32. Pivotal advance: inhibition of HMGB1 nuclear translocation as a mechanism for the anti-rheumatic effects of gold sodium thiomalate.
Zetterström CK; Jiang W; Wähämaa H; Ostberg T; Aveberger AC; Schierbeck H; Lotze MT; Andersson U; Pisetsky DS; Erlandsson Harris H
J Leukoc Biol; 2008 Jan; 83(1):31-8. PubMed ID: 17913975
[TBL] [Abstract][Full Text] [Related]
33. Stimulated T cells generate microparticles, which mimic cellular contact activation of human monocytes: differential regulation of pro- and anti-inflammatory cytokine production by high-density lipoproteins.
Scanu A; Molnarfi N; Brandt KJ; Gruaz L; Dayer JM; Burger D
J Leukoc Biol; 2008 Apr; 83(4):921-7. PubMed ID: 18223103
[TBL] [Abstract][Full Text] [Related]
34. Is HMGB1 an osteocyte alarmin?
Bidwell JP; Yang J; Robling AG
J Cell Biochem; 2008 Apr; 103(6):1671-80. PubMed ID: 17948903
[TBL] [Abstract][Full Text] [Related]
35. Dealing with death: HMGB1 as a novel target for cancer therapy.
Lotze MT; DeMarco RA
Curr Opin Investig Drugs; 2003 Dec; 4(12):1405-9. PubMed ID: 14763124
[TBL] [Abstract][Full Text] [Related]
36. Construction and characterization of the HMGB1 mutant as a competitive antagonist to HMGB1 induced cytokines release.
Yuan Z; Chen J; Zhang Y; Peng Y
Biochem Biophys Res Commun; 2008 Aug; 372(4):703-7. PubMed ID: 18515078
[TBL] [Abstract][Full Text] [Related]
37. PACAP inhibit the release and cytokine activity of HMGB1 and improve the survival during lethal endotoxemia.
Tang Y; Lv B; Wang H; Xiao X; Zuo X
Int Immunopharmacol; 2008 Dec; 8(12):1646-51. PubMed ID: 18713653
[TBL] [Abstract][Full Text] [Related]
38. HMGB1 as a cytokine and therapeutic target.
Yang H; Wang H; Czura CJ; Tracey KJ
J Endotoxin Res; 2002; 8(6):469-72. PubMed ID: 12697092
[TBL] [Abstract][Full Text] [Related]
39. High mobility group box-1 protein acts as a coactivator of nuclear factor of activated T cells-2 in promoting interleukin-2 transcription.
Liu H; Yao YM; Ding LH; Zhang H; Yuan B; Song Q; Ye QN; Huang CF; Sheng ZY
Int J Biochem Cell Biol; 2009 Mar; 41(3):641-8. PubMed ID: 18707018
[TBL] [Abstract][Full Text] [Related]
40. [Reactivity of human peripheral blood lymphocyte to alpha-Gal on porcine arotic endothelial cell].
Li Y; Li T; Ma Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1998 Nov; 12(6):359-62. PubMed ID: 10437092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
